Akkermansia muciniphila (ATCC BAA-835) was provided from the DSMZ institute (German Collection of Microorganisms and Cell Cultures GmbH).
A. muciniphila strains were cultured in brain heart infusion (BHI) agar medium (Quelab, Canada) supplemented with 0.5%
mucin-type III (Sigma-Aldrich, St. Louis, Missouri, USA), hemin (5 μg/ml), menadione (1 μg/ml)
45 (link) and 0.05% L-cysteine
46 (link) under anaerobic conditions (80% N
2, 10% H
2, and 10% CO
2) at 37 °C for 3–7 days as described previously
12 (link).
Polymerase chain reaction (PCR) test was performed based on 16 s ribosomal ribonucleic acid (rRNA) sequence recognition to confirm the
A. muciniphila, in addition to macroscopic and microscopic (Gram staining) assays (Supplementary Table
1).
Cell-free supernatant was obtained from the inoculation of
A. muciniphila in 100 mL BHI broth with the above-mentioned supplementations incubated in the same condition reaching optical density (OD) of 1.5 in 600 nm, centrifuged in 8000 × g for 5 min; the pH was adjusted in 7.4 and then purified by passing through 2.22 nm filters and kept at −70 °C until usage.
Ghaderi F., Sotoodehnejadnematalahi F., Hajebrahimi Z., Fateh A, & Siadat S.D. (2022). Effects of active, inactive, and derivatives of Akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes. Scientific Reports, 12, 10031.